Stage IIIB Breast Cancer, Stage IIIA Breast Cancer, Stage II Breast Cancer, Stage IB Breast Cancer, Stage IA Breast Cancer, Peripheral Neuropathy, Neurotoxicity, Male Breast Cancer and Stage IIIC Breast Cancer Clinical Trial Using questionnaire administration and laboratory biomarker analysis

- The folks at Fox Chase Cancer Center are studying the effects of laboratory biomarker analysis; questionnaire administration on Stage IIIB Breast Cancer, Stage IIIA Breast Cancer, Stage II Breast Cancer, Stage IB Breast Cancer, Stage IA Breast Cancer, Peripheral Neuropathy, Neurotoxicity, Male Breast Cancer and Stage IIIC Breast Cancer in individuals ages 18 years and older. This clinical trial is slated to start January 2011.

Overall Study Contact Info
StatusName Contact Phone
Recruiting

This study is officially titled, "Assessing Heavy Metal Contributions to Neurotoxicity in Breast Cancer Patients Undergoing Adjuvant or Neoadjuvant Chemotherapy."

Locations

Fox Chase Cancer Center

Philadelphia, Pennsylvania - Recruiting

Paoli Memorial Hospital

Paoli, Pennsylvania - Recruiting

Lincoln University

Lincoln University, Pennsylvania - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.